Guest guest Posted January 22, 2012 Report Share Posted January 22, 2012 Invest in ME The 7th Invest in ME International ME/CFS Conference 2012 Building a Future for Research into ME Clinical and Research Updates in Myalgic Encephalomyelitis Welcome to IIMEC7 - the 7th Invest in ME International ME/CFS Conference 2012 in Westminster, London, UK, on 1st June 2012. Today Invest in ME announce some of the speakers at the 2012 conference. The key to resolving, treating and curing ME/CFS lies in biomedical research. Healthcare staff need to be aware of the latest biomedical research into ME/CFS as well as the multiple symptoms exhibited by ME/CFS patients and of the possible treatments available and future research directions. Benefits of attending Invest in ME 2012 Conference o Increase your understanding of diagnosis, treatment and management of ME o Explore current and future biomedical research into ME o Assess the role of immunological markers in ME o Learn about ongoing clinical trials using Rituximab to treat ME patients o Learn about inflammation in the CNS and its contribution to neurological disease o Learn about the function of the immune response in the gut o Share and exchange ideas with the leading practitioners in the field Who should attend? IIMEC7 will be of interest to: o Specialists in ME (CFS) o GPs with an interest in ME (CFS) o Neurologists o Immunologists o Virologists o Palliative care nurses o Occupational Therapists o Specialists in pain management o Specialists in care of the chronically ill o Community nurses o All trainees in these disciplines o ME Support groups and charities ````````````` Conference fee includes: Entrance to the conference, lunch & refreshments, full conference documentation and certificate of accreditation (for professionals). Confirmed Speakers: Invest in ME are pleased to announce the following speakers at the conference - Dr Staines Associate Professor, Bond University, Public Health Physician, Australia Professor Olav Mella University of Bergen, Institute of Medicine, Section for Oncology Dr Øystein Fluge University of Bergen, Institute of Medicine, Section for Oncology Dr Sonya Marshall-Gradisnik Associate Professor, Biochemistry, Bond University, Australia Professor Hugh Professor of Experimental Neuropathology, University of Southampton Dr Delgado Head of Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine, Spain Dr Simmaron Research, USA Dr Ian Gibson Former Dean of Biological Sciences, University of East Anglia Additional speakers are expected to be announced shortly ````````````` Also present at the conference will be representatives of the European ME Alliance (EMEA) as the EMEA AGM takes place after the conference. CPD Accreditation from the Royal colleges has been applied for and we hope to obtain the maximum credits for the conference, as in previous years. ````````````` How can we ensure ME research and patient care benefit from the latest thinking in ME/CFS and related areas of research? What is the best way forward? The Invest in ME conferences have attracted presenters and delegates from fifteen countries and our DVDs of the conferences have been distributed to over 20 countries in Europe, USA, Canada, Australia and New Zealand. Conference Registration: Full details of the conference can be found at this address - click: http://bit.ly/A0dMPf IiME are again offering a discounted rate for healthcare staff who attend in connection with a local ME Support Group. IiME welcome all professionals who are working with, or have an interest in, ME/CFS. Should you have any further questions relating to the conference please contact us at meconference@.... We look forward to welcoming you to the conference, Invest in ME ````````````` Invest in ME UK Registered Charity Nr. 1114035 Invest in ME, PO BOX 561, Eastleigh SO50 0GQ, Hampshire, UK Support ME Awareness - Invest in ME Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.